Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Total Liabilities: 2009-2025

Historic Total Liabilities for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $191.9 million.

  • Lifecore Biomedical's Total Liabilities fell 4.07% to $191.9 million in Q2 2025 from the same period last year, while for May 2025 it was $191.9 million, marking a year-over-year decrease of 4.07%. This contributed to the annual value of $191.9 million for FY2025, which is 4.07% down from last year.
  • Lifecore Biomedical's Total Liabilities amounted to $191.9 million in FY2025, which was down 4.07% from $200.1 million recorded in FY2024.
  • Over the past 5 years, Lifecore Biomedical's Total Liabilities peaked at $299.9 million during FY2021, and registered a low of $186.9 million during FY2022.
  • Over the past 3 years, Lifecore Biomedical's median Total Liabilities value was $200.1 million (recorded in 2024), while the average stood at $203.5 million.
  • Per our database at Business Quant, Lifecore Biomedical's Total Liabilities tumbled by 37.69% in 2022 and then rose by 16.90% in 2023.
  • Lifecore Biomedical's Total Liabilities (Yearly) stood at $299.9 million in 2021, then tumbled by 37.69% to $186.9 million in 2022, then grew by 16.90% to $218.5 million in 2023, then fell by 8.42% to $200.1 million in 2024, then declined by 4.07% to $191.9 million in 2025.